Sanofi to Aquire Inhibrx for $1.7 Billion - BioPharm International

Retrieved on: 2024-01-29 16:49:17

Tags for this article:

Click the tags to see associated articles and topics

Sanofi to Aquire Inhibrx for $1.7 Billion - BioPharm International. View article details on hiswai:

Excerpt

On Jan, 23, 2024, Sanofi announced its planned acquisition of Inhibrx, a clinical-stage biopharmaceutical, in a deal valued at approximately $1.7 ...

Article found on: www.biopharminternational.com